Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.2K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.2K
Drug Discovery: Overview01:26

Drug Discovery: Overview

8.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.8K
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

150
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
150
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

126
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
126
Protein-Drug Binding: Determination Methods01:22

Protein-Drug Binding: Determination Methods

308
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
308

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Correction to "Large-Scale Compartmental Model-Based Study of Preclinical Pharmacokinetic Data and Its Impact on Compound Triaging in Drug Discovery".

Molecular pharmaceutics·2026
Same author

Conformal Selection for Efficient and Accurate Compound Screening in Drug Discovery.

Journal of chemical information and modeling·2025
Same author

A novel high-dimensional model for identifying regional DNA methylation QTLs.

Biostatistics (Oxford, England)·2025
Same author

A flexible machine learning Mendelian randomization estimator applied to predict the safety and efficacy of sclerostin inhibition.

American journal of human genetics·2025
Same author

Large-Scale Compartmental Model-Based Study of Preclinical Pharmacokinetic Data and Its Impact on Compound Triaging in Drug Discovery.

Molecular pharmaceutics·2025
Same author

Machine Learning Informed Diagnosis for Congenital Heart Disease in Large Claims Data Source.

JACC. Advances·2024

相关实验视频

Updated: Sep 13, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.5K

QComp:用于药物发现的基于QSAR的推算框架.

Bingjia Yang1, Yunsie Chung2, Archer Y Yang3

  • 1Pharmacokinetics, Dynamics, Metabolism, and Bioanalytical, Merck & Co., Inc., South San Francisco, California 94080, United States.

Journal of chemical information and modeling
|July 28, 2025
PubMed
概括

QSAR-Complete (QComp) 通过快速将新的实验数据整合到定量结构-活性关系 (QSAR) 模型中,改善了药物发现. 该框架增强了缺失数据的归算,并指导实验设计,以有效评估化合物.

更多相关视频

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

14.1K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.7K

相关实验视频

Last Updated: Sep 13, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.5K
In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

14.1K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.7K

科学领域:

  • 药物的发现和开发.
  • 计算化学是一种计算化学.
  • 生物化学 生物化学

背景情况:

  • 药物发现依赖于体外和体内实验中的生物化学活性数据.
  • 大量,稀疏和不断变化的数据集对传统的定量结构-活动关系 (QSAR) 模型构成挑战.
  • 敏捷地将新的实验数据集成到QSAR模型中,对于高效的药物开发至关重要.

研究的目的:

  • 开发一个归算框架,QSAR-Complete (QComp),以解决现有的QSAR模型在处理不断变化的实验数据方面的局限性.
  • 通过利用现有的QSAR模型,使新的实验数据能够立即利用.
  • 改进缺少的生物化学活性数据的归算.

主要方法:

  • 开发了QSAR-Complete (QComp) 的归算框架.
  • 利用现有的QSAR模型来处理新的实验数据,而无需进行广泛的再培训.
  • 量化减少统计不确定性以指导实验设计.

主要成果:

  • QComp强大而显著地改善了仅使用体外实验数据的体内测试数据的归算.
  • 该框架能够灵活地整合新的实验数据,克服传统QSAR模型再培训的缓慢步伐.
  • QComp有效量化了不确定性降低,有助于选择最佳实验.

结论:

  • QSAR-Complete (QComp) 通过通过QSAR建模来增强实验数据的使用,在药物发现方面取得了重大进展.
  • 该框架有助于在药物发现管道中进行更合理,更有效的决策.
  • QComp改善了数据归算和实验规划,加速了化合物疗效和毒性的评估.